Patents by Inventor Lan Jiang

Lan Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11634418
    Abstract: The invention relates to compounds of formula (I): or a salt thereof, wherein R1, R5, R7, R8, X, m, n, p and q are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating tissue specific fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: April 25, 2023
    Assignee: Pliant Therapeutics, Inc.
    Inventors: David John Morgans, Jr., Randall L. Halcomb, Gustave Bergnes, Hui Li, Lan Jiang, Jacob Cha, Timothy Hom
  • Patent number: 11613546
    Abstract: The present disclosure relates generally to certain tricyclic compounds, pharmaceutical compositions comprising said compounds, and methods of making said compounds and pharmaceutical compositions. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.
    Type: Grant
    Filed: January 18, 2022
    Date of Patent: March 28, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley, Lan Jiang, Jiayao Li, David W. Lin, Michael L. Mitchell, Devan Naduthambi, Gregg M. Schwarzwälder, Suzanne M. Szewczyk, Matthew J. Von Bargen, Qiaoyin Wu, Hong Yang, Jennifer R. Zhang
  • Publication number: 20230027019
    Abstract: Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2, L, W1, W2, X, Y, and Z are as defined herein. Methods associated with the preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
    Type: Application
    Filed: June 29, 2021
    Publication date: January 26, 2023
    Inventors: Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang, Jiayao Li, Michael L. Mitchell, Hyung-Jung Pyun, Scott D. Schroeder, Gregg M. Schwarzwalder, Nathan D. Shapiro, Devleena M. Shivakumar, Qiaoyin Wu, Hong Yang, Jennifer R. Zhang
  • Patent number: 11560376
    Abstract: The invention relates to compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ?v?6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: January 24, 2023
    Assignee: Pliant Therapeutics, Inc.
    Inventors: Jacob Cha, Chengguo Dong, Timothy Hom, Lan Jiang, Katerina Leftheris, Hui Li, David John Morgans, Jr., Manuel Munoz, Maureen Reilly, Yajun Zheng, Christopher Bailey, Darren Finklestein
  • Patent number: 11547039
    Abstract: A fully-automatic transplanting combined machine includes a traction apparatus, operation apparatus and a control system. The operation apparatus is mounted on the traction apparatus with a main body frame and is towed behind the traction apparatus. The operation apparatus includes a rotary tillage furrowing system, a system for slightly preparing soil and opening narrow furrows, a planting system, and a soil covering compacting system which are arranged successively from front to back. The planting system includes more than one planting unit. The fully-automatic transplanting combined machine is capable of orderly performing rotary tillage, cleaning stubble, leveling a border check, opening a furrow, cutting narrow slits, transplanting, covering soil, compacting soil in untilled soil at one process, so as to create the soil requirements for high-speed transplanting of blanket seedlings such as rape and other crops.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: January 10, 2023
    Assignee: Nanjing Institute of Agricultural Mechanization, Ministry of Agriculture and Rural Affairs
    Inventors: Chongyou Wu, Qing Tang, Jun Wu, Min Zhang, Gang Wang, Lan Jiang
  • Patent number: 11548887
    Abstract: The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): wherein R1, R2, R3, A, and G are defined in the specification, or a pharmaceutically-acceptable salt or solvate thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: January 10, 2023
    Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
    Inventors: Daniel D. Long, John R. Jacobsen, Lan Jiang
  • Patent number: 11548902
    Abstract: Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2, L, W1, W2, X, Y, and Z are as defined herein. Methods associated with the preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: January 10, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Lan Jiang, Jiayao Li, Michael L. Mitchell, Hyung-Jung Pyun, Scott D. Schroeder, Gregg M. Schwarzwälder, Nathan D. Shapiro, Devleena M. Shivakumar, Qiaoyin Wu, Hong Yang, Jennifer R. Zhang
  • Publication number: 20220340535
    Abstract: The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer.
    Type: Application
    Filed: February 9, 2021
    Publication date: October 27, 2022
    Inventors: Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang, Darryl Kato, Tetsuya Kobayashi, John E. Knox, Scott E. Lazerwith, Xiaofen Li, David W. Lin, Jonathan W. Medley, Michael L. Mitchell, Devan Naduthambi, Zachary Newby, Neil H. Squires, Vickie H. Tsui, Chandrasekar Venkataramani, William J. Watkins, Hong Yang
  • Publication number: 20220313110
    Abstract: The present disclosure relates a method, device, electronic apparatus, and system of providing information for breathing training, and storage medium. The method of providing information for breathing training includes receiving first data input on a first display interface, the first data including breathing training time data; and presenting output data on a second display interface, the output data including breathing beat image prompting an exhaling action and an inhaling action by using alternate graphics.
    Type: Application
    Filed: November 25, 2019
    Publication date: October 6, 2022
    Inventors: Yanyang HU, Hongliang WANG, Xu ZHANG, Lan JIANG
  • Publication number: 20220313821
    Abstract: The present disclosure relates to a multifunctional therapeutic biological material and preparation method thereof. The process steps of the preparation method are as follows: (1) preparing various three-dimensional micro/nano composite structure on the surface of a biomedical material by using femtosecond laser double pulses; (2) further preparing a nano-flower structure on the three-dimensional micro/nano composite structure by using hydrothermal synthesis method to construct a heterogeneous structure consisting of the three-dimensional micro/nano composite structure and the nano-flower structure; (3) putting the prepared heterogeneous structure into a mixed solution containing gold ions and platinum ions, and by using ultraviolet light reduction method, reducing in situ into gold-platinum bimetallic nanoparticles on the heterogeneous structure to obtain the multifunctional therapeutic biological material.
    Type: Application
    Filed: October 1, 2021
    Publication date: October 6, 2022
    Inventors: Lan JIANG, Yunlong MA, Jie HU
  • Publication number: 20220319679
    Abstract: A public event administrating system is disclosed. The public event involves a plurality of individuals and the administrating system includes: a data collecting module, a data processing module, a medical resource scheduling module, and a grid administrating module. The data collecting module is configured to acquire initial data about the public event from a plurality of data sources. The data processing module is configured to process the initial data to acquire processed data. The medical resource scheduling module is configured to receive an individual service request and allocate currently available medical resources to an individual requesting service at least according to the individual service request. And, the grid administrating module is configured to divide a geographic region managed by the administrating system into a plurality of grids, and assign a plurality of grid administrators to the plurality of grids to respectively administrate individuals in the plurality of grids.
    Type: Application
    Filed: February 28, 2020
    Publication date: October 6, 2022
    Inventors: Hongliang WANG, Yanyang HU, Fang ZHAI, Guoqiang ZHANG, Yubin ZHOU, Fuchen TIAN, Lan JIANG
  • Publication number: 20220306624
    Abstract: The invention provides compounds of formula (I): wherein X is and the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are useful as JAK kinase inhibitors. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat respiratory diseases, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: March 7, 2022
    Publication date: September 29, 2022
    Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
    Inventors: Paul R. Fatheree, John R. Jacobsen, Anne-Marie Beausoleil, Gary E.L. Brandt, Melissa Fleury, Lan Jiang, Cameron Smith, Steven D.E. Sullivan, Lori Jean Van Orden, Pierre-Jean Colson, Gene Timothy Fass, Miroslav Rapta, Noah Benjamin, Marta Dabros, Venkat R. Thalladi
  • Publication number: 20220274957
    Abstract: The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I) wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: January 12, 2022
    Publication date: September 1, 2022
    Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
    Inventors: Robert Murray McKinnell, Roland Gendron, Lan Jiang, Seok-Ki Choi, Daniel D. Long, Paul R. Fatheree, Daniel Marquess
  • Publication number: 20220267343
    Abstract: The present disclosure relates generally to certain tricyclic compounds, pharmaceutical compositions comprising said compounds, and methods of making said compounds and pharmaceutical compositions. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.
    Type: Application
    Filed: January 18, 2022
    Publication date: August 25, 2022
    Inventors: Hang Chu, Ana Z. Gonzalez Buenrostro, Hongyan Guo, Xiaochun Han, Anna E. Hurtley, Lan Jiang, Jiayao Li, David W. Lin, Michael L. Mitchell, Devan Naduthambi, Gregg M. Schwarzwalder, Suzanne M. Szewczyk, Matthew J. Von Bargen, Qiaoyin Wu, Hong Yang, Jennifer R. Zhang
  • Patent number: 11352261
    Abstract: The present disclosure relates to a graphene-nanoflower shaped MXene composite material, preparation method and application thereof, which belongs to the field of negative electrode materials for supercapacitors. In the present disclosure, a space-time shaping femtosecond laser is utilized to process MXene target in graphene oxide nanoflake dispersion, so as to synthesize a graphene-nanoflower shaped MXene composite material in one-step. This nanoflower shaped MXene has adjustable size and morphology and an extremely large specific surface area; when it is used in an electrode material for supercapacitors, the supercapacitor exhibits an extremely high specific capacitance and good cycle stability. This method utilizes a space-time shaping femtosecond laser to synthesize the graphene-nanoflower shaped MXene composite material, which is highly controllable, and can be used to uniformly prepare the material in large-scale. It has provided a new way for synthesis of materials.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: June 7, 2022
    Assignee: BEIJING INSTITUTE OF TECHNOLOGY
    Inventors: Lan Jiang, Yongjiu Yuan, Xin Li
  • Publication number: 20220142553
    Abstract: When generating anatomical maps (e.g., anatomical geometries and/or electrophysiology maps), it can be desirable to analyze whether or not a collected data point was collected from a region of interest. During an electrophysiology study, for example, an electroanatomical mapping system collects electrophysiology data points, each including an electrogram signal. By defining both a window of interest and a window of exclusion within the electrogram signal, the electroanatomical mapping system can analyze collected data points to determine whether or not they should be included in a map. In particular, the electroanatomical mapping system can compare the electrophysiology signal within the window of interest and the window of exclusion with respect to at least one signal parameter and add the data point to the map if the comparison satisfies at least one corresponding inclusion criterion. Applicable signal parameters include maximum peak-to-peak voltage, conduction velocity, and electrogram morphology.
    Type: Application
    Filed: February 11, 2020
    Publication date: May 12, 2022
    Inventors: Craig Markovitz, Jan O. MANGUAL-SOTO, Chun-lan JIANG, Louis-Philippe RICHER, Cyrille CASSET
  • Publication number: 20220135565
    Abstract: Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof. Methods associated with the preparation and use of the disclosed compounds, as well as pharmaceutical compositions comprising such compounds are also disclosed.
    Type: Application
    Filed: September 29, 2021
    Publication date: May 5, 2022
    Inventors: Hang Chu, Hongyan Guo, Lan Jiang, Jiayao Li, David W. Lin, Hyung-Jung Pyun, Qiaoyin Wu, Hong Yang, Adam D. Zajdlik, Jennifer R. Zhang
  • Patent number: 11313971
    Abstract: A three-dimensional imaging system and method are provided. The three-dimensional imaging system includes: an ultrashort pulse laser light source configured to generate a detection beam; a supercontinuum spectrum generator configured to generate a supercontinuum spectrum based on the detection beam passing through the supercontinuum spectrum generator; a pulse separation delayer configured to generate a continuous pulse sequence of different wavelengths with a time interval based on the supercontinuum spectrum; a multi-frequency pulse interference fringe generator configured to generate multi-frequency interference fringe patterns of different wavelength ranges with a time interval based on the continuous pulse sequence; and an image acquisition device configured to acquire an optical signal reflected by a sample irradiated by the multi-frequency interference fringe patterns to obtain a three-dimensional topography of the sample.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: April 26, 2022
    Assignee: BEIJING INSTITUTE OF TECHNOLOGY
    Inventors: Lan Jiang, Baoshan Guo, Tianyong Zhang
  • Patent number: 11299492
    Abstract: The invention provides compounds of formula (I): wherein X is and the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are useful as JAK kinase inhibitors. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat respiratory diseases, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: April 12, 2022
    Assignee: Theravance Biopharma R&D IP, LLC
    Inventors: Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Melissa Fleury, Lan Jiang, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden, Anne-Marie Beausoleil
  • Patent number: 11253953
    Abstract: A method and a device for processing a unidirectional flow surface, the method includes: generating a grayscale map having gradually changed grayscale values; generating a holographic phase map having a bionic light spot with gradually changed energies based on the grayscale map; loading the holographic phase map onto a spatial beam shaper; and focusing a laser beam on a surface of an object to be processed after the laser beam passes through the spatial beam shaper, to process structural units having unidirectional flow characteristics on the surface of the object to be processed.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: February 22, 2022
    Assignee: BEIJING INSTITUTE OF TECHNOLOGY
    Inventors: Lan Jiang, Xiaozhe Chen, Xin Li, Xiaojie Li, Misheng Liang